REQUEST A DEMO
Total
USD $0.00
Search more companies

Medycyna Molekularna Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Pharmaceutical Preparation Manufacturing | Other Industrial Machinery Manufacturing | Other Information Services | All Other Information Services | Veterinary Services | All Other Professional, Scientific, and Technical Services | Educational Support Services | All Other Miscellaneous Ambulatory Health Care Services
Full name: Medycyna Molekularna Sp. z o.o. Profile Updated: May 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English & Polish Download a sample report

Medycyna Molekularna Sp. z o.o. is a company based in Poland, with its head office in Poznan. It operates in the Research and Development in Biotechnology (except Nanobiotechnology) sector. It was incorporated on November 30, 2016. Its’ total assets recorded a growth of 14.48%.

Headquarters
Ul. Grunwaldzka 50/26
Poznan; Wielkopolskie; Postal Code: 60-311

Contact Details: Purchase the Medycyna Molekularna Sp. z o.o. report to view the information.

Website: http://www.medycynamolekularna.pl

Basic Information
Outstanding Shares:
Purchase the Medycyna Molekularna Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Medycyna Molekularna Sp. z o.o. report to view the information.
Incorporation Date:
November 30, 2016
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
90%
Purchase this report to view the information.
10%
Subsidiaries
Biosensors Lab P.S.A.
100%
Molecular Medicine Sp. z o.o.
100%
Ps Technologies Sp. z o.o.
100%
Company Performance
Financial values in the chart are available after Medycyna Molekularna Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
N/A
Total assets
14.48%
Total equity
22.58%
Return on Equity (ROE)
N/A

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?